Stratification by Hb levels within the erythrocytosis group in this study revealed no significant association with thrombosis risk, consistent with Gangat et al.'s finding of no direct link between Hb levels and thrombosis in SGLT-2 inhibitor-associated erythrocytosis [11]. This evidence concerns the gene SLC5A2 and Venous thrombosis.